
Bruker
🇺🇸 NASDAQ:BRKR
•
Dec 31, 2024
Bruker Q4 2024 Earnings Report
Key Takeaways
Bruker reported strong revenue growth of 14.6% YoY in Q4 2024, reaching $979.6M, primarily driven by acquisitions (+11.9%). However, net income dropped significantly (-93.3% YoY) due to higher expenses and acquisition-related costs. Adjusted EPS increased by 8.6% to $0.76.
Bruker Revenue
Bruker EPS
Bruker Revenue by Segment
Bruker Revenue by Geographic Location
Forward Guidance
Bruker expects revenue growth of 3% to 5% in FY 2025, with strong contributions from acquisitions and organic growth. Adjusted EPS is projected to rise 11% to 13%.
Positive Outlook
- Revenue expected to grow 3% to 5%
- Organic revenue growth projected at 3% to 4%
- Acquisition-driven revenue growth forecasted at 2% to 3%
- Non-GAAP EPS expected to increase 11% to 13%
- Operational improvements expected to drive margin expansion
Challenges Ahead
- Foreign currency headwinds projected at approximately 2%
- Potential macroeconomic uncertainties impacting demand
- Integration costs from recent acquisitions still a factor
- Higher debt levels from acquisitions may impact financial flexibility
- Increased tax rate could continue to affect net income
Revenue & Expenses
Visualization of income flow from segment revenue to net income